The latest market price trends and purchasing channels for furosemide subcutaneous injection in 2025
Furosemide subcutaneous injection (FUROSCIX), an innovative loop diuretic for patients with chronic heart failure, is typically administered subcutaneously via a wearable, pre-programmed disposable infusion set. FUROSCIX is designed to be used safely and effectively in a home setting, providing diuretic efficacy comparable to hospital IV administration. However, the drug is not currently available in the Chinese market, so information about its price and purchase channels is relatively limited.
In overseas markets, the original product of furosemide subcutaneous injection is generally sold in the specification of 80mg/10mL, and the price is about more than 900 US dollars. This price is subject to change due to exchange rate fluctuations. It should be noted that the drug supply of furosemide subcutaneous injection is usually in the form of kits. Each kit contains all the required equipment and drugs to facilitate self-administration by patients or caregivers. At the same time, the supply of furosemide subcutaneous injection is affected by the drug regulatory policies of various countries, so the selling price and sales channels in different countries will also be different.

Regarding purchasing channels, in countries such as the United States, furosemide subcutaneous injection can be obtained through prescription pharmacies. Patients need to obtain a prescription under the guidance of a doctor and then go to the pharmacy to purchase it. In addition, some pharmacies may also provide ordering services for furosemide subcutaneous injection, but patients also need to provide a valid prescription. It is very important to choose a trustworthy pharmacy and platform for purchase to ensure the quality and safety of the medicine. There is currently no generic version of furosemide subcutaneous injection, which means that patients can only have access to the original product in overseas markets. This also reflects the uniqueness and market scarcity of furosemide subcutaneous injection as a new treatment option.
Reference materials:https://www.drugs.com/price-guide/furoscix
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)